Get started
Author

Krystin M. Mantione

Observed name: Krystin Mantione
ORCID: 0000-0002-0977-1966
Observed ORCID: 0000-0002-0977-1966
OpenAlex ID: A5052074994
A Phase Ib Study of the FGFR/VEGFR Inhibitor Dovitinib With Gemcitabine and Capecitabine in Advanced Solid Tumor and Pancreatic Cancer Patients
2018 · Wen Wee Ma, Hao Xie, et al. · American Journal of Clinical Oncology · 32
Serum‐free complete medium, an alternative medium to mimic androgen deprivation in human prostate cancer cell line models
2017 · Michael V. Fiandalo, John H. Wilton, et al. · The Prostate · 17
Inhibition of dihydrotestosterone synthesis in prostate cancer by combined frontdoor and backdoor pathway blockade
2018 · Michael V. Fiandalo, John J. Stocking, et al. · Oncotarget · 16
Glucocorticoids are induced while dihydrotestosterone levels are suppressed in 5‐alpha reductase inhibitor treated human benign prostate hyperplasia patients
2022 · Renjie Jin, Connor Forbes, et al. · The Prostate · 15
Androgen activity in the male embryonic hindbrain drives lethal PFA ependymoma
2026 · Jiao Zhang, Winnie Ong, et al. · Nature · 3
Mp87-12 Adrenal Androgens Facilitate Prostate Cancer Cell Resistance to Androgen Deprivation Therapy
2017 · Michael Fiandalo, John Stocking, et al. · The Journal of Urology · 1
Abstract 7565: Psychological distress, antidepressants, and sympathetic-immune profiles in cancer survivors.
2026 · Ji E. Park, Andrew Ray, et al. · Cancer Research
Newly Diagnosed AML Exhibits Significant Differences in Immune Metabolic Pathways and Inflammatory States in Contrast to Patients with Relapsed/Refractory Disease
2023 · Amanda C. Przespolewski, Spencer Rosario, et al. · Blood
PDF
Pd05-09 Fluorescent-dihydrotestosterone Based Inhibitor Impaired Prostate Cancer Cell Line Growth and Androgen Receptor Signaling
2019 · Michael Fiandalo*, Vitaliy Sviripa, et al. · The Journal of Urology
Works count: 9
Citation count: 84
H-index: 4
I10-index: 4
Year
Topic
Type